Μετάβαση στο περιεχόμενο

Ετικέταchronic lymphocytic leukemia

Novartis’s Breast Cancer Drug Looks Promising in Phase III Trial, Despite Category’s Troubling History

Novartis announced that its BYL719 (alpelisib) met the primary endpoint of progression-free survival (PFS) in its Phase III SOLAR-1 trial. The drug is an alpha-specific PI3K inhibitor, a category of cancer drugs … Continue Reading Novartis’s Breast Cancer Drug Looks Promising in Phase III Trial, Despite Category’s Troubling History